Curis Inc

Ownership Transactions Reported by 11 Insiders

Symbol: CRIS on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 128 Spring Street, Building C, Suite 500, Lexington, Massachusetts

There are no Buy or Sell transactions made by insiders since 9/12/2023

Curis Inc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
William Steinkrauss	Chief Financial Officer	$4.18M			Jan 29, 2022
Robert Martell	Head of Research & Development	$4.07M			Jan 20, 2023
James E. Dentzer	President & CEO, Director	$1.16M			May 21, 2024
Lori Anne Kunkel	Director	$988K			Jan 31, 2022
Jonathan B. Zung	Cdo	$473K			May 21, 2024
Diantha Duvall	Cfo	$453K			May 21, 2024
John Hohneker	Director	$49.4K			May 21, 2024
Martyn D. Greenacre	Director	$49.4K			May 21, 2024
Kenneth I. Kaitin	Director	$49.4K			May 21, 2024
Marc Rubin	Director	$49.4K			May 21, 2024
Anne Borgman	Director	$49.4K			May 21, 2024

Recent Insider Transactions by Companies or Individuals for Curis Inc

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.